[ad_1]
The government predicted that the vaccine will be vaccinated against Corona 19 in Korea after the second quarter of next year.
Joon-wook Kwon, deputy director of the Central Defense Countermeasures Headquarters, said in a periodic briefing on Corona 19 on the 10th: “If you obtain a vaccine through international organizations, examine the side effects and carefully complement your vaccination strategy. with national experts, and take a cold chain, it will be after the second quarter (next year). We are judging whether we should make practical preparations in order to secure and proceed. “
This is the explanation given by quarantine authorities amid growing interest at the time of corona 19 vaccination when the American pharmaceutical company Pfizer announced that the Corona 19 vaccine, which is developed jointly with the German Bio En Tech, is effective to prevent more than 90%.
Deputy General Manager Kwon Jun-wook said: “Regarding side effects, I have said that I will take at least two months after the vaccination is completely finished, but I think the vaccine will be approved in December.” “In addition to Pfizer, other companies will announce clinical trials and some countries will begin vaccination within this year. I think it will work. “
Then “Pfizer has 43,000 clinical trial subjects,” he said. “Side effects can appear in 100,000 or 1 in 1 million, and if 500,000 or 1 million or more are inoculated in other countries, it will be completely complete and even have side effects. You can think of it as an alternative to see and follow.”
Related Posts
Pfizer develops a ‘90% effective ‘vaccine … Can you see the end of the’ Crown Tunnel ‘
Minister Ki-Young Choi “Quickly Secure Corona Treatment and Vaccine”
Next year’s budget of 264.4 billion won for corona treatment and vaccine development
Government “Promotion of ensuring at least 70% of the population of the Corona 19 vaccine”
He also said: “Even if the safety of the vaccine is the highest priority, even if the pre-purchase of (vaccine) does everything possible, it may be an adverse reaction that was not thought further after receiving more than 500,000 to 1 million vaccinations in the country where the vaccine was given before actual citizens. It’s much more important to check. “
Deputy Director General Kwon said: “Except for transparency and pricing issues, we are talking and discussing seriously with all institutions that have entered phase 3 clinical trials.” “It is better to make sure that people can proceed with confidence and stability without feeling anxious. I’ll do my best.”
